• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体在肝细胞癌的发病机制、诊断和治疗中的作用

Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma.

作者信息

Li Shuang, Chen Limin

机构信息

Institute of Basic Medicine, Shanghai University of Medicine and Health Sciences, Shanghai, China.

Provincial Key Laboratory for Transfusion-Transmitted Infectious Diseases, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China.

出版信息

Front Oncol. 2022 Jan 27;12:793432. doi: 10.3389/fonc.2022.793432. eCollection 2022.

DOI:10.3389/fonc.2022.793432
PMID:35155236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8828506/
Abstract

Exosomes are extracellular vesicles with a diameter of 30-150 nm that are released by most types of cells and have been confirmed to be involved in many physical and pathological processes, especially in cell to cell communication. Compared with other vesicles, exosomes have a unique double-layer saclike structure that allows them to be present stably in various body fluids, including blood, cerebrospinal fluid, urine, saliva, and serous cavity effusion. The cargoes of exosomes reflect the characteristics of host cells. Due to the nature of hepatocellular carcinoma (HCC) cells, heterogeneity in the bioactive substances usually exist in exosomes. In addition, exosomes can efficiently deliver cargoes to the target cells to exert pathological functions, playing important role in tumor occurrence, development, metastasis, immune regulation, and drug resistance. Previous studies have been shown that exosomes have wide applications in diagnosis and treatment of HCC. In this review, we discuss these recent findings and highlight the significant roles of exosomes in HCC, focusing on the effect and underlying mechanisms of exosomes to regulate HCC progression and the potential clinical value of exosomes as biomarkers and therapeutic targets.

摘要

外泌体是直径为30-150纳米的细胞外囊泡,由大多数类型的细胞释放,并且已被证实参与许多生理和病理过程,尤其是在细胞间通讯中。与其他囊泡相比,外泌体具有独特的双层囊状结构,这使得它们能够稳定存在于包括血液、脑脊液、尿液、唾液和浆膜腔积液在内的各种体液中。外泌体的货物反映了宿主细胞的特征。由于肝癌(HCC)细胞的性质,外泌体中生物活性物质通常存在异质性。此外,外泌体可以有效地将货物递送至靶细胞以发挥病理功能,在肿瘤发生、发展、转移、免疫调节和耐药性中起重要作用。先前的研究表明,外泌体在HCC的诊断和治疗中具有广泛应用。在本综述中,我们讨论了这些最新发现,并强调了外泌体在HCC中的重要作用,重点关注外泌体调节HCC进展的作用及潜在机制,以及外泌体作为生物标志物和治疗靶点的潜在临床价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1243/8828506/75a5d6be6642/fonc-12-793432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1243/8828506/a12d657f00a0/fonc-12-793432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1243/8828506/75a5d6be6642/fonc-12-793432-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1243/8828506/a12d657f00a0/fonc-12-793432-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1243/8828506/75a5d6be6642/fonc-12-793432-g002.jpg

相似文献

1
Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma.外泌体在肝细胞癌的发病机制、诊断和治疗中的作用
Front Oncol. 2022 Jan 27;12:793432. doi: 10.3389/fonc.2022.793432. eCollection 2022.
2
Exosomes in head and neck cancer: Roles, mechanisms and applications.头颈部癌症中的外泌体:作用、机制与应用。
Cancer Lett. 2020 Dec 1;494:7-16. doi: 10.1016/j.canlet.2020.07.005. Epub 2020 Aug 8.
3
Exosome in Hepatocellular Carcinoma: an update.肝细胞癌中的外泌体:最新进展
J Cancer. 2021 Mar 5;12(9):2526-2536. doi: 10.7150/jca.54566. eCollection 2021.
4
Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma.外泌体在肝细胞癌耐药中的独特作用的当前观点
J Hepatocell Carcinoma. 2022 Feb 18;9:99-112. doi: 10.2147/JHC.S351038. eCollection 2022.
5
Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine.外泌体在肝细胞癌中的作用及中医药调控
Front Pharmacol. 2023 Jan 17;14:1110922. doi: 10.3389/fphar.2023.1110922. eCollection 2023.
6
Exosomes as potent regulators of HCC malignancy and potential bio-tools in clinical application.外泌体作为肝癌恶性肿瘤的有效调节因子及临床应用中的潜在生物工具。
Int J Clin Exp Med. 2015 Oct 15;8(10):17088-95. eCollection 2015.
7
Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.外泌体介导的肿瘤微环境通讯促进肝癌的发生和发展。
J Hematol Oncol. 2019 May 29;12(1):53. doi: 10.1186/s13045-019-0739-0.
8
Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma.外泌体在肝细胞癌免疫治疗中的作用
Cancers (Basel). 2022 Aug 21;14(16):4036. doi: 10.3390/cancers14164036.
9
Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma.外泌体在肝细胞癌免疫微环境中的作用
J Oncol. 2022 Jan 28;2022:2521025. doi: 10.1155/2022/2521025. eCollection 2022.
10
Exosomes in hepatocellular carcinoma: a new horizon.肝细胞癌中的细胞外囊泡:新的视野。
Cell Commun Signal. 2019 Jan 7;17(1):1. doi: 10.1186/s12964-018-0315-1.

引用本文的文献

1
Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential.细胞外囊泡在脂肪变性相关肝病中的作用及其治疗潜力。
World J Hepatol. 2024 Sep 27;16(9):1211-1228. doi: 10.4254/wjh.v16.i9.1211.
2
Cathelicidin Antimicrobial Peptide Acts as a Tumor Suppressor in Hepatocellular Carcinoma.抗菌肽 Cathelicidin 在肝细胞癌中作为肿瘤抑制因子发挥作用。
Int J Mol Sci. 2023 Oct 27;24(21):15652. doi: 10.3390/ijms242115652.
3
Advances in Histological and Molecular Classification of Hepatocellular Carcinoma.

本文引用的文献

1
Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.外泌体 S100A4 来源于高转移性肝癌细胞,通过激活 STAT3 促进转移。
Signal Transduct Target Ther. 2021 May 26;6(1):187. doi: 10.1038/s41392-021-00579-3.
2
Downregulation of hsa_circ_0074854 Suppresses the Migration and Invasion in Hepatocellular Carcinoma via Interacting with HuR and via Suppressing Exosomes-Mediated Macrophage M2 Polarization.hsa_circ_0074854 的下调通过与 HuR 相互作用并抑制外泌体介导的巨噬细胞 M2 极化来抑制肝癌的迁移和侵袭。
Int J Nanomedicine. 2021 Apr 12;16:2803-2818. doi: 10.2147/IJN.S284560. eCollection 2021.
3
肝细胞癌组织学和分子分类的进展
Biomedicines. 2023 Sep 20;11(9):2582. doi: 10.3390/biomedicines11092582.
4
Disparities in Cisplatin-Induced Cytotoxicity-A Meta-Analysis of Selected Cancer Cell Lines.顺铂诱导细胞毒性的差异-选定癌细胞系的荟萃分析。
Molecules. 2023 Jul 30;28(15):5761. doi: 10.3390/molecules28155761.
5
Potential role of human umbilical cord stem cells-derived exosomes as novel molecular inhibitors of hepatocellular carcinoma growth.人脐带间充质干细胞来源的外泌体作为新型肝癌生长分子抑制剂的潜在作用。
Apoptosis. 2023 Oct;28(9-10):1346-1356. doi: 10.1007/s10495-023-01863-z. Epub 2023 Jun 20.
6
Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy.肝细胞癌的发病机制:细胞凋亡与自噬的相互作用
Biomedicines. 2023 Apr 13;11(4):1166. doi: 10.3390/biomedicines11041166.
7
Exosomes-mediated crosstalk between glioma and immune cells in the tumor microenvironment.外泌体介导的肿瘤微环境中胶质瘤与免疫细胞间的串扰。
CNS Neurosci Ther. 2023 Aug;29(8):2074-2085. doi: 10.1111/cns.14239. Epub 2023 May 11.
8
An Insight into the Arising Role of MicroRNAs in Hepatocellular Carcinoma: Future Diagnostic and Therapeutic Approaches.浅析 microRNAs 在肝细胞癌中的涌现角色:未来的诊断和治疗方法。
Int J Mol Sci. 2023 Apr 12;24(8):7168. doi: 10.3390/ijms24087168.
9
Role of noncoding RNAs in liver fibrosis.非编码 RNA 在肝纤维化中的作用。
World J Gastroenterol. 2023 Mar 7;29(9):1446-1459. doi: 10.3748/wjg.v29.i9.1446.
10
Advances in Purification, Modification, and Application of Extracellular Vesicles for Novel Clinical Treatments.用于新型临床治疗的细胞外囊泡的纯化、修饰及应用进展
Membranes (Basel). 2022 Dec 8;12(12):1244. doi: 10.3390/membranes12121244.
RETRACTED: Hepatocellular carcinoma cells-derived exosomal microRNA-378b enhances hepatocellular carcinoma angiogenesis.
撤回:肝细胞癌细胞衍生的外泌体 microRNA-378b 增强肝癌血管生成。
Life Sci. 2021 May 15;273:119184. doi: 10.1016/j.lfs.2021.119184. Epub 2021 Feb 10.
4
Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1.外泌体MiR-1290通过靶向SMEK1促进肝细胞癌血管生成。
J Oncol. 2021 Jan 29;2021:6617700. doi: 10.1155/2021/6617700. eCollection 2021.
5
Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma.外泌体 LINC00161 通过调节 miR-590-3p/ROCK 轴促进肝癌血管生成和转移。
Cancer Gene Ther. 2021 Jun;28(6):719-736. doi: 10.1038/s41417-020-00269-2. Epub 2021 Jan 7.
6
Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765.癌细胞来源的外泌体 linc-FAM138B 通过调节 miR-765 缓解肝癌进展。
Aging (Albany NY). 2020 Dec 26;12(24):26236-26247. doi: 10.18632/aging.202430.
7
CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1.环状 RNA-SORE 通过稳定 YBX1 介导肝癌对索拉非尼的耐药性。
Signal Transduct Target Ther. 2020 Dec 26;5(1):298. doi: 10.1038/s41392-020-00375-5.
8
M1 Macrophage-Derived Exosomal MicroRNA-326 Suppresses Hepatocellular Carcinoma Cell Progression Via Mediating NF-κB Signaling Pathway.M1巨噬细胞衍生的外泌体微小RNA-326通过介导NF-κB信号通路抑制肝癌细胞进展。
Nanoscale Res Lett. 2020 Dec 2;15(1):221. doi: 10.1186/s11671-020-03432-8.
9
Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.人脐带间充质干细胞来源的外泌体 microRNA-451a 通过抑制 ADAM10 抑制肝癌细胞上皮-间充质转化。
RNA Biol. 2021 Oct;18(10):1408-1423. doi: 10.1080/15476286.2020.1851540. Epub 2020 Dec 31.
10
Current perspectives on the tumor microenvironment in hepatocellular carcinoma.当前对肝癌肿瘤微环境的看法。
Hepatol Int. 2020 Dec;14(6):947-957. doi: 10.1007/s12072-020-10104-3. Epub 2020 Nov 13.